Stoke Therapeutics, Inc

(NASDAQ:STOK)

Latest On Stoke Therapeutics, Inc (STOK):

Date/Time Type Description Signal Details
2023-05-04 17:05 ESTNewsStoke Therapeutics GAAP EPS of -$0.53 beats by $0.15, revenue of $5.15M beats by $1.65MN/A
2023-05-01 14:11 ESTNewsStoke Therapeutics upgraded to neutral at BoA on Dravet candidateN/A
2023-04-26 22:19 ESTNewsStoke Therapeutics a buy at Canaccord on platform for genetic diseasesN/A
2023-04-25 22:00 ESTNewsStoke stock rises after UK regulator nod to start trial of eye disorder drugN/A
2023-03-15 17:15 ESTNewsStoke gets FDA nod to use higher dose of epilepsy drug in ongoing trialN/A
2023-03-06 19:36 ESTNewsStoke Therapeutics GAAP EPS of -$0.65 beats by $0.05, revenue of $3.27M beats by $0.41MN/A
2023-02-12 09:04 ESTNewsStoke Therapeutics Looks Unfairly ValuedN/A
2022-11-28 18:27 ESTNewsBuy Stoke Therapeutics At A Deep Discount Following Early Data In Dravet SyndromeN/A
2022-11-14 15:38 ESTNewsStoke Therapeutics GAAP EPS of -$0.66 beats by $0.02, revenue of $2.91M beats by $0.19MN/A
2022-11-14 15:37 ESTNewsStoke Therapeutics drops 27% after early data for anti-seizure medicineN/A
2022-08-09 08:23 ESTNewsStoke Therapeutics GAAP EPS of -$0.63 beats by $0.05, revenue of $3.2M beats by $0.18MN/A
2022-05-10 14:29 ESTNewsStoke Therapeutics GAAP EPS of -$0.66 misses by $0.98, revenue of $3M misses by $34.5MN/A
2022-03-10 22:22 ESTNewsStoke Therapeutics GAAP EPS of -$0.66 misses by $0.04N/A
2022-01-31 23:13 ESTNewsStoke Therapeutics initiated Buy at Jefferies on potential of RNA platformN/A
2022-01-25 02:45 ESTNewsStoke Therapeutics (STOK) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2021-12-03 21:14 ESTNewsStoke Therapeutics shares data from Phase 1/2a trial for STK-001 in Dravet syndromeN/A
2021-12-01 09:31 ESTNewsWarning: STOK is at high risk of performing badlyN/A
2021-12-01 09:31 ESTNewsStoke Therapeutics (STOK) Investor Presentation -SlideshowN/A
2021-11-23 08:45 ESTNewsStoke Therapeutics up 14% following J.P. Morgan upgrade to overweightN/A
2021-11-08 19:21 ESTNewsStoke Therapeutics EPS misses by $0.02N/A
2021-09-22 07:07 ESTNewsStoke Therapeutics posts interim results from early-stage STK-001 Dravet syndrome studyN/A
2021-08-10 12:23 ESTNewsStoke Therapeutics EPS misses by $0.12N/A
2021-03-30 13:19 ESTNewsStoke Therapeutics gets MHRA greenlight for early-stage Dravet syndrome studyN/A
2021-03-11 20:54 ESTFinancialsCompany financials have been released.Neutral
2021-03-11 12:29 ESTAnalyst RatingThe Analyst Target Price has increased from $63.75 to $65.38.Buy
2021-03-11 00:51 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-11 00:51 ESTAnalyst RatingThe Analyst Target Price has increased from $60.38 to $63.75.Buy
2021-03-11 00:51 ESTEarnings EstimateAn EPS average of -$2.12 is estimated for the 2022 year.Sell
2021-03-10 04:53 ESTFinancialsCompany financials have been released.Neutral
2021-03-07 14:56 ESTNewsSizing Up Stoke TherapeuticsN/A
2021-02-11 08:36 ESTAnalyst RatingThe Analyst Target Price has increased from $59.5 to $60.38.Neutral
2021-02-10 19:01 ESTNewsStoke cut to neutral at Wedbush seeking a ‘better entry point’N/A
2021-01-29 08:37 ESTAnalyst RatingThe Analyst Target Price has increased from $57.63 to $59.5.Neutral
2021-01-15 08:37 ESTAnalyst RatingThe Analyst Target Price has increased from $56.5 to $57.63.Neutral
2020-12-29 08:37 ESTAnalyst RatingThe Analyst Target Price has increased from $54.13 to $56.5.Neutral
2020-12-16 13:07 ESTAnalyst RatingThe Analyst Target Price has increased from $49.13 to $54.13.Neutral
2020-12-14 08:52 ESTAnalyst RatingThe Analyst Target Price has increased from $48.13 to $49.13.Neutral
2020-12-14 08:12 ESTNewsStoke Therapeutics: A Preclinical Biopharma With A Multibillion Dollar Market CapN/A
2020-11-26 21:40 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 03:45 ESTNewsStoke Therapeutics prices $97.5M public offeringN/A
2020-11-19 00:23 ESTNewsStoke Therapeutics -2.7% AH, proposes public offeringN/A
2020-11-17 05:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 05:28 ESTAnalyst RatingThe Analyst Target Price has increased from $47.13 to $48.13.Buy
2020-11-14 21:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 13:26 ESTEarnings EstimateAn EPS average of -$0.44 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-13 13:26 ESTAnalyst RatingThe Analyst Target Price has increased from $41.5 to $47.13.Buy
2020-11-13 10:25 ESTNewsStoke Therapeutics EPS in-lineN/A
2020-11-08 00:59 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-04 18:01 ESTInsider TradeHuw M. Nash has directly disposed of 2,536 shares and currently holds 0 shares.Sell

About Stoke Therapeutics, Inc (STOK):

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary ribonucleic acid therapeutics platform, Targeted Augmentation of Nuclear Gene Output (TANGO), to design ASOs to upregulate the expression of protein by individual genes in a patient. Its lead product candidate is STK-001 that is used to treat Dravet syndrome, a severe and progressive genetic epilepsy. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

STOK Quotes by TradingView

See Advanced Chart

General

  • Name Stoke Therapeutics, Inc
  • Symbol STOK
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 79
  • Fiscal Year EndDecember
  • IPO Date2019-06-19
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.stoketherapeutics.com
View More

Valuation

  • Trailing PE 21.65
  • Price/Book (Most Recent Quarter) 6.47
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.80
  • Next Year EPS Estimate -$2.10
  • Next Quarter EPS Estimate -$0.44
  • Return on Assets -13%
  • Return on Equity -20%
  • Earnings Per Share -$11.44
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.78 billion
  • EBITDA -22302000
  • PE Ratio -7.4
  • Analyst Target Price $65.38
  • Book Value Per Share $7.14
View More

Share Statistics

  • Shares Outstanding 36.66 million
  • Shares Float 12.64 million
  • % Held by Insiders 170%
  • % Held by Institutions 98.06%
  • Shares Short 3.3 million
  • Shares Short Prior Month 3.37 million
  • Short Ratio 27.54
  • Short % of Float 21%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • 52 Week High $71.58
  • 52 Week Low $17.55
  • 50 Day Moving Average 58.62
  • 200 Day Moving Average 48.97
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Stoke Therapeutics, Inc (STOK) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Stoke Therapeutics, Inc (STOK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$0.42-$0.420.92%
2020-09-302020-11-12$N/A-$0.41-$0.434.58%
2020-06-302020-08-10$N/A-$0.39-$0.36-8.33%
2020-03-312020-05-15$N/A-$0.34-$0.378.87%
2019-12-312020-03-23$N/A-$0.09-$0.3069.63%
2019-09-302019-11-12$N/A-$0.26-$0.285.83%
2019-06-302019-08-14$N/A-$1.54-$1.635.39%

Stoke Therapeutics, Inc (STOK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Stoke Therapeutics, Inc (STOK) Chart:

Stoke Therapeutics, Inc (STOK) News:

Below you will find a list of latest news for Stoke Therapeutics, Inc (STOK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Stoke Therapeutics, Inc (STOK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-1512.50CALL0 11478.86TRUE00
2026-05-151517.89CALL0 0447.31TRUE00
2026-05-1517.50CALL0 194323.58TRUE00
2026-05-152013.7CALL0 23328.67TRUE00
2026-05-1522.59CALL0 49238.5TRUE00
2026-05-15250CALL0 8211.7TRUE00
2026-05-15303.1CALL0 210TRUE00
2026-05-15350.66CALL1 96110.61FALSE-0.01-0.01
2026-05-15400.3CALL0 119172.39FALSE00
2026-05-15450CALL0 297304.74FALSE00
2026-05-15500CALL0 164501.77FALSE00
2026-05-15550CALL0 0557.61FALSE00
2026-05-1512.50PUT0 201112.63FALSE00
2026-05-15150PUT0 15935.08FALSE00
2026-05-1517.50PUT0 16790.04FALSE00
2026-05-15200.1PUT0 77384.77FALSE00
2026-05-1522.50PUT0 14557.71FALSE00
2026-05-15250.17PUT1 20175.41FALSE0.170
2026-05-15300.71PUT1 2290131.72FALSE0.210.42
2026-05-15352.96PUT1 126106.53TRUE2.960
2026-05-15400PUT0 50TRUE00
2026-05-15450PUT0 10TRUE00
2026-05-155016.87PUT0 0244.28TRUE00
2026-05-15550PUT0 0253.2TRUE00
2026-06-1817.50CALL0 0135.02TRUE00
2026-06-182013.1CALL0 31145.29TRUE00
2026-06-1822.50CALL0 0110.88TRUE00
2026-06-18250CALL0 097.61TRUE00
2026-06-18305.5CALL1 399.19TRUE5.50
2026-06-18351.5CALL0 4076.04FALSE00
2026-06-18401.3CALL6 183.83FALSE00
2026-06-18450CALL0 0140.71FALSE00
2026-06-18500CALL0 2162.13FALSE00
2026-06-18550CALL0 1180.28FALSE00
2026-06-1817.50PUT0 0257.25FALSE00
2026-06-18200PUT0 0100.14FALSE00
2026-06-1822.50PUT0 0181.87FALSE00
2026-06-18250PUT0 0149.91FALSE00
2026-06-18300PUT0 097.18FALSE00
2026-06-18354.07PUT8 864.64TRUE-0.93-0.19
2026-06-18408.27PUT8 275.99TRUE8.270
2026-06-18450PUT0 072.11TRUE00
2026-06-185017.6PUT1 1888.95TRUE0.60.04
2026-06-18550PUT0 0100.01TRUE00
2026-08-2117.50CALL0 2105.7TRUE00
2026-08-21200CALL0 7102.75TRUE00
2026-08-2122.50CALL0 389.31TRUE00
2026-08-21250CALL0 2289.82TRUE00
2026-08-21307CALL0 3885.25TRUE00
2026-08-21354.58CALL0 8178.36FALSE00
2026-08-21402.9CALL0 3785.13FALSE00
2026-08-21452.05CALL3 1378.45FALSE2.050
2026-08-21500CALL0 3099.02FALSE00
2026-08-21551.05CALL0 12110.17FALSE00
2026-08-2117.50PUT0 20158.09FALSE00
2026-08-21200PUT0 1383.04FALSE00
2026-08-2122.50PUT0 6112.07FALSE00
2026-08-21250PUT0 692.58FALSE00
2026-08-21300PUT0 2981.31FALSE00
2026-08-21356.6PUT0 5895.69TRUE00
2026-08-21400PUT0 175.54TRUE00
2026-08-21450PUT0 2876.73TRUE00
2026-08-21500PUT0 3475.11TRUE00
2026-08-21550PUT0 073.93TRUE00
2026-11-2017.50CALL0 390.73TRUE00
2026-11-20200CALL0 188.38TRUE00
2026-11-2022.50CALL0 087.34TRUE00
2026-11-20250CALL0 087.82TRUE00
2026-11-20300CALL0 1485.05TRUE00
2026-11-20350CALL0 082.16FALSE00
2026-11-20406CALL0 181.84FALSE00
2026-11-20450CALL0 281.33FALSE00
2026-11-20503.48CALL1 482.62FALSE3.480
2026-11-2017.51.35PUT0 1116.04FALSE00
2026-11-20200PUT0 399.16FALSE00
2026-11-2022.50PUT0 490.33FALSE00
2026-11-20250PUT0 087.47FALSE00
2026-11-20300PUT0 081.24FALSE00
2026-11-20358.75PUT3 581.56TRUE-0.15-0.02
2026-11-20400PUT0 078.14TRUE00
2026-11-20450PUT0 078.26TRUE00
2026-11-20500PUT0 078.54TRUE00

Latest STOK Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST13$10.47
Jun 13, 2022 7:59 PM EST60$10.47
Jun 13, 2022 7:59 PM EST20$10.47
Jun 13, 2022 7:59 PM EST41$10.47
Jun 13, 2022 7:59 PM EST15$10.47

Stoke Therapeutics, Inc (STOK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120040613/0001209191-20-040613-index.htm
2019-04-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1623526/000000000019007260/0000000000-19-007260-index.htm
2019-05-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1623526/000000000019008485/0000000000-19-008485-index.htm
2019-06-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1623526/000000000019009270/0000000000-19-009270-index.htm
2019-06-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1623526/000000000019009719/0000000000-19-009719-index.htm
2020-07-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1623526/000000000020006449/0000000000-20-006449-index.htm
2019-07-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1623526/000092963819000658/0000929638-19-000658-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1623526/000092963820000333/0000929638-20-000333-index.htm
2019-03-26DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1623526/000095012319002845/0000950123-19-002845-index.htm
2019-04-30DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1623526/000095012319003688/0000950123-19-003688-index.htm
2019-04-30DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1623526/000095012319003690/0000950123-19-003690-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1623526/000110465920021017/0001104659-20-021017-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000114420419031374/0001144204-19-031374-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000114420419032095/0001144204-19-032095-index.htm
2019-05-23S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1623526/000119312519155301/0001193125-19-155301-index.htm
2019-05-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1623526/000119312519155321/0001193125-19-155321-index.htm
2019-06-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1623526/000119312519163789/0001193125-19-163789-index.htm
2019-06-07S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1623526/000119312519167576/0001193125-19-167576-index.htm
2019-06-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1623526/000119312519167579/0001193125-19-167579-index.htm
2019-06-118-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1623526/000119312519170268/0001193125-19-170268-index.htm
2019-06-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1623526/000119312519171310/0001193125-19-171310-index.htm
2019-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1623526/000119312519171314/0001193125-19-171314-index.htm
2019-06-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1623526/000119312519173255/0001193125-19-173255-index.htm
2019-06-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1623526/000119312519173266/0001193125-19-173266-index.htm
2019-06-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1623526/000119312519175848/0001193125-19-175848-index.htm
2019-06-18S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1623526/000119312519175863/0001193125-19-175863-index.htm
2019-06-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1623526/000119312519176488/0001193125-19-176488-index.htm
2019-07-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1623526/000119312519186323/0001193125-19-186323-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312519220567/0001193125-19-220567-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312519308649/0001193125-19-308649-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520005877/0001193125-20-005877-index.htm
2020-03-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1623526/000119312520082470/0001193125-20-082470-index.htm
2020-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520108110/0001193125-20-108110-index.htm
2020-04-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1623526/000119312520113542/0001193125-20-113542-index.htm
2020-04-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1623526/000119312520113561/0001193125-20-113561-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520139879/0001193125-20-139879-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520160684/0001193125-20-160684-index.htm
2020-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520189990/0001193125-20-189990-index.htm
2020-07-10S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1623526/000119312520191098/0001193125-20-191098-index.htm
2020-07-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1623526/000119312520193961/0001193125-20-193961-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520221818/0001193125-20-221818-index.htm
2020-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520226962/0001193125-20-226962-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000119312520265127/0001193125-20-265127-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120016360/0001209191-20-016360-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120021312/0001209191-20-021312-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120021314/0001209191-20-021314-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120021317/0001209191-20-021317-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120021319/0001209191-20-021319-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120021321/0001209191-20-021321-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120021322/0001209191-20-021322-index.htm
2020-04-153/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120024540/0001209191-20-024540-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120024543/0001209191-20-024543-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120024546/0001209191-20-024546-index.htm
2020-05-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120032142/0001209191-20-032142-index.htm
2020-05-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120032146/0001209191-20-032146-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120032149/0001209191-20-032149-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034091/0001209191-20-034091-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/0001209191-20-034096-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034101/0001209191-20-034101-index.htm
2020-06-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034721/0001209191-20-034721-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034723/0001209191-20-034723-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034729/0001209191-20-034729-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034731/0001209191-20-034731-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034732/0001209191-20-034732-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034735/0001209191-20-034735-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120034737/0001209191-20-034737-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120040613/0001209191-20-040613-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120042004/0001209191-20-042004-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120042007/0001209191-20-042007-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120042943/0001209191-20-042943-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120044723/0001209191-20-044723-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120048841/0001209191-20-048841-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/0001209191-20-049551-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/0001209191-20-050031-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/0001209191-20-053732-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120054703/0001209191-20-054703-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/0001209191-20-055378-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/0001209191-20-056950-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2019-06-13CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1623526/000135445719000309/0001354457-19-000309-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000149315219009407/0001493152-19-009407-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000149315219009471/0001493152-19-009471-index.htm
2019-06-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1623526/000149315219009851/0001493152-19-009851-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000149315219014877/0001493152-19-014877-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000149315219016346/0001493152-19-016346-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000149315219016566/0001493152-19-016566-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000149315219016926/0001493152-19-016926-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1623526/000149315220002386/0001493152-20-002386-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1623526/000156459019032126/0001564590-19-032126-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000156459019042621/0001564590-19-042621-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1623526/000156459019042891/0001564590-19-042891-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000156459020012112/0001564590-20-012112-index.htm
2020-03-2310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1623526/000156459020012202/0001564590-20-012202-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000156459020025636/0001564590-20-025636-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1623526/000156459020025637/0001564590-20-025637-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1623526/000156459020038587/0001564590-20-038587-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1623526/000156459020038905/0001564590-20-038905-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013623/0001567619-19-013623-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013624/0001567619-19-013624-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013625/0001567619-19-013625-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013626/0001567619-19-013626-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013627/0001567619-19-013627-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013628/0001567619-19-013628-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013629/0001567619-19-013629-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013630/0001567619-19-013630-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013631/0001567619-19-013631-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013632/0001567619-19-013632-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013633/0001567619-19-013633-index.htm
2019-06-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013662/0001567619-19-013662-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013838/0001567619-19-013838-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919013840/0001567619-19-013840-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919018220/0001567619-19-018220-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919018221/0001567619-19-018221-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919018222/0001567619-19-018222-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919018223/0001567619-19-018223-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919018224/0001567619-19-018224-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919018225/0001567619-19-018225-index.htm
2019-11-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919021770/0001567619-19-021770-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000156761919021771/0001567619-19-021771-index.htm
2014-11-24DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000162352614000001/0001623526-14-000001-index.htm
2018-11-02DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1623526/000162352618000002/0001623526-18-000002-index.htm
2019-06-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1623526/999999999519001367/9999999995-19-001367-index.htm
2020-07-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1623526/999999999520001866/9999999995-20-001866-index.htm
2019-06-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1623526/999999999719005333/9999999997-19-005333-index.htm
2019-06-13SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1623526/999999999719005455/9999999997-19-005455-index.htm

Stoke Therapeutics, Inc (STOK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stoke Therapeutics, Inc (STOK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 170%
Institutional Ownership: 9806%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Huw M. NashCOO & CBOSell15,995.0026.37421,852.130.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120016360/0001209191-20-016360-index.htm
2020-06-01Huw M. NashCOO & CBOSell500.0027.4813,742.000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034091/0001209191-20-034091-index.htm
2020-07-01Huw M. NashCOO & CBOSell3,800.0023.1587,967.720.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120040613/0001209191-20-040613-index.htm
2020-07-07Huw M. NashCOO & CBOSell913.0022.4120,456.860.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120042004/0001209191-20-042004-index.htm
2020-07-16Huw M. NashCOO & CBOSell1,900.0025.0647,614.000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120042943/0001209191-20-042943-index.htm
2020-08-03Huw M. NashCOO & CBOSell5,700.0024.73140,943.330.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120044723/0001209191-20-044723-index.htm
2020-08-28Huw M. NashCOO & CBOSell2,081.0030.0062,430.000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120048841/0001209191-20-048841-index.htm
2020-09-01Huw M. NashCOO & CBOSell700.0028.7120,097.630.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/0001209191-20-049551-index.htm
2020-09-08Huw M. NashCOO & CBOSell30,718.0030.00921,540.000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/0001209191-20-050031-index.htm
2020-09-09Huw M. NashCOO & CBOSell17,201.0030.00516,030.000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/0001209191-20-050031-index.htm
2020-10-01Huw M. NashCOO & CBOSell2,300.0034.8680,182.600.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/0001209191-20-053732-index.htm
2020-11-02Huw M. NashCOO & CBOSell2,536.0037.9896,324.890.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/0001209191-20-056950-index.htm
2020-07-07Robin A. WalkerChief Legal Officer, CCO & SecSell941.0022.5021,172.500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120042007/0001209191-20-042007-index.htm
2020-11-02Stephen J TulipanoCFOSell14,445.0037.86546,909.371,002.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2020-06-01Barry TichoChief Medical OfficerBuy131,147.000.6078,688.20131,147.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034101/0001209191-20-034101-index.htm
2020-03-31Gene LiauEVP Research & Preclinical DevBuy7,500.000.604,500.0013,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120024546/0001209191-20-024546-index.htm
2020-05-22Gene LiauEVP Research & Preclinical DevSell7,500.0030.00225,000.0013,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120032149/0001209191-20-032149-index.htm
2020-06-01Gene LiauEVP Research & Preclinical DevSell1,230.0027.4833,801.5113,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/0001209191-20-034096-index.htm
2020-10-13Gene LiauEVP Research & Preclinical DevSell1,649.0040.0065,960.0013,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120054703/0001209191-20-054703-index.htm
2020-10-16Gene LiauEVP Research & Preclinical DevSell5,851.0040.00234,041.7613,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/0001209191-20-055378-index.htm
2020-10-19Gene LiauEVP Research & Preclinical DevSell7,225.0038.42277,585.9513,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/0001209191-20-055378-index.htm
2020-06-01Gene LiauEVP Research & Preclinical DevSell7,875.0026.91211,920.9814,730.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/0001209191-20-034096-index.htm
2020-10-13Gene LiauEVP Research & Preclinical DevBuy1,649.000.60989.4015,149.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120054703/0001209191-20-054703-index.htm
2020-11-02Stephen J TulipanoCFOSell20,155.0036.79741,448.0315,447.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2020-03-02Huw M. NashCOO & CBOSell33,148.0025.66850,697.0115,995.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120016360/0001209191-20-016360-index.htm
2019-06-21Apple Tree Partners IV, L.P.10% Share HolderBuy1,388,889.0018.0025,000,002.0016,786,713.00https://www.sec.gov/Archives/edgar/data/1623526/000156761919013838/0001567619-19-013838-index.htm
2019-06-21Seth Loring HarrisonDirectorBuy1,388,889.0018.0025,000,002.0016,786,713.00https://www.sec.gov/Archives/edgar/data/1623526/000156761919013840/0001567619-19-013840-index.htm
2020-11-04Stephen J TulipanoCFOSell16,941.0040.03678,085.5516,929.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2020-09-09Huw M. NashCOO & CBOBuy17,201.002.1937,670.1917,201.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/0001209191-20-050031-index.htm
2020-06-01Barry TichoChief Medical OfficerSell365.0027.9810,212.70172,662.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034101/0001209191-20-034101-index.htm
2020-06-01Barry TichoChief Medical OfficerSell1,000.0027.1727,174.00173,027.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034101/0001209191-20-034101-index.htm
2020-06-01Barry TichoChief Medical OfficerBuy42,880.002.1993,907.20174,027.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034101/0001209191-20-034101-index.htm
2020-07-16Huw M. NashCOO & CBOBuy1,900.002.194,161.001,900.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120042943/0001209191-20-042943-index.htm
2020-10-16Gene LiauEVP Research & Preclinical DevBuy5,851.000.603,510.6019,351.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/0001209191-20-055378-index.htm
2020-10-19Gene LiauEVP Research & Preclinical DevSell24,775.0037.64932,578.0720,725.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/0001209191-20-055378-index.htm
2020-08-28Huw M. NashCOO & CBOBuy2,081.002.194,557.392,081.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120048841/0001209191-20-048841-index.htm
2020-05-22Gene LiauEVP Research & Preclinical DevBuy7,500.000.604,500.0021,000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120032149/0001209191-20-032149-index.htm
2020-06-01Huw M. NashCOO & CBOBuy2,107.002.194,614.332,107.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034091/0001209191-20-034091-index.htm
2020-06-01Gene LiauEVP Research & Preclinical DevSell10,895.0025.82281,314.3522,605.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/0001209191-20-034096-index.htm
2020-10-01Huw M. NashCOO & CBOSell3,400.0034.33116,717.922,300.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/0001209191-20-053732-index.htm
2020-11-03Stephen J TulipanoCFOBuy1,732.004.487,759.362,334.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2020-11-02Huw M. NashCOO & CBOSell3,164.0036.59115,785.002,536.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/0001209191-20-056950-index.htm
2020-09-08Huw M. NashCOO & CBOBuy30,718.002.1967,272.4230,718.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120050031/0001209191-20-050031-index.htm
2020-06-01Gene LiauEVP Research & Preclinical DevBuy20,000.002.1943,800.0033,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034096/0001209191-20-034096-index.htm
2019-06-19RTW INVESTMENTS, LP10% Share HolderBuy555,556.0018.0010,000,008.003,355,466.00https://www.sec.gov/Archives/edgar/data/1623526/000149315219009471/0001493152-19-009471-index.htm
2020-11-04Stephen J TulipanoCFOBuy33,268.004.48149,040.6433,870.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2019-10-01RTW INVESTMENTS, LP10% Share HolderBuy31,560.0021.96693,029.203,387,026.00https://www.sec.gov/Archives/edgar/data/1623526/000149315219014877/0001493152-19-014877-index.htm
2019-10-30RTW INVESTMENTS, LP10% Share HolderBuy41,438.0028.791,193,004.163,428,464.00https://www.sec.gov/Archives/edgar/data/1623526/000149315219016346/0001493152-19-016346-index.htm
2019-10-31RTW INVESTMENTS, LP10% Share HolderBuy18,747.0028.15527,658.693,447,211.00https://www.sec.gov/Archives/edgar/data/1623526/000149315219016346/0001493152-19-016346-index.htm
2019-11-01RTW INVESTMENTS, LP10% Share HolderBuy8,598.0028.61245,950.093,455,809.00https://www.sec.gov/Archives/edgar/data/1623526/000149315219016346/0001493152-19-016346-index.htm
2019-11-08RTW INVESTMENTS, LP10% Share HolderSell16,434.0028.70471,631.153,544,248.00https://www.sec.gov/Archives/edgar/data/1623526/000149315219016926/0001493152-19-016926-index.htm
2020-11-02Stephen J TulipanoCFOBuy35,000.004.48156,800.0035,602.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2019-11-04RTW INVESTMENTS, LP10% Share HolderBuy104,873.0029.243,066,843.093,560,682.00https://www.sec.gov/Archives/edgar/data/1623526/000149315219016566/0001493152-19-016566-index.htm
2020-07-01Huw M. NashCOO & CBOBuy3,800.002.198,322.003,800.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120040613/0001209191-20-040613-index.htm
2020-10-19Gene LiauEVP Research & Preclinical DevBuy30,497.000.6018,298.2043,997.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/0001209191-20-055378-index.htm
2020-10-19Gene LiauEVP Research & Preclinical DevBuy1,503.002.193,291.5745,500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120055378/0001209191-20-055378-index.htm
2020-03-02Huw M. NashCOO & CBOBuy42,779.002.1993,686.0149,103.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120016360/0001209191-20-016360-index.htm
2020-06-01Huw M. NashCOO & CBOSell1,607.0027.0843,521.26500.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120034091/0001209191-20-034091-index.htm
2019-12-16Edward M. MD KayeCEOBuy50,000.000.6030,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120024543/0001209191-20-024543-index.htm
2020-08-03Huw M. NashCOO & CBOBuy5,700.002.1912,483.005,700.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120044723/0001209191-20-044723-index.htm
2020-09-01Huw M. NashCOO & CBOBuy5,700.002.1912,483.005,700.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/0001209191-20-049551-index.htm
2020-10-01Huw M. NashCOO & CBOBuy5,700.002.1912,483.005,700.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120053732/0001209191-20-053732-index.htm
2020-11-02Huw M. NashCOO & CBOBuy5,700.002.1912,483.005,700.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056950/0001209191-20-056950-index.htm
2020-11-04Stephen J TulipanoCFOSell11,111.0041.42460,214.295,818.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2019-12-20Gene LiauEVP Research & Preclinical DevBuy6,000.000.603,600.006,000.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120024546/0001209191-20-024546-index.htm
2020-11-02Stephen J TulipanoCFOSell400.0038.4415,374.00602.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2020-11-03Stephen J TulipanoCFOSell1,732.0039.8468,997.51602.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2020-11-04Stephen J TulipanoCFOSell5,216.0041.97218,909.78602.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120056953/0001209191-20-056953-index.htm
2020-03-02Huw M. NashCOO & CBOBuy6,324.000.402,529.606,324.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120016360/0001209191-20-016360-index.htm
2020-09-01Huw M. NashCOO & CBOSell5,000.0027.60138,015.00700.00https://www.sec.gov/Archives/edgar/data/1623526/000120919120049551/0001209191-20-049551-index.htm